• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部放疗后单发区域性复发后的生存和疾病进展。

Survival and disease progression following solitary locoregional recurrence after head and neck radiotherapy.

机构信息

Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas, USA.

Department of Otolaryngology, UT Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Head Neck. 2022 May;44(5):1153-1163. doi: 10.1002/hed.27012. Epub 2022 Feb 25.

DOI:10.1002/hed.27012
PMID:35212070
Abstract

PURPOSE

The management of solitary locoregional recurrence (sLRR) of head and neck squamous cell carcinoma (HNSCC) previously treated with radiotherapy (RT) is challenging. We aimed to identify characteristics associated with improved outcome.

METHODS

We identified patients treated with non-sinus, mucosal HNSCC who initially received IMRT. We characterized overall survival (OS) and locoregional control (LRC). Multivariable analysis (MVA) on survival and patterns-of-failure were performed using Cox and Fine-Gray competing risks analysis.

RESULTS

We identified 90 patients with available follow-up. In total, 67 (74%) patients received curative-intent salvage, while 23 (26%) received palliative care. On MVA, significantly improved OS and LRC were associated with lower initial N-classification and use of salvage total laryngectomy (TL) or neck dissection (ND).

CONCLUSION

A nontrivial number of patients with sLRR cannot undergo salvage. Among patients treated with curative intent, TL or ND were clearly associated with improved OS and LRC.

摘要

目的

头颈部鳞状细胞癌(HNSCC)经放疗(RT)治疗后发生孤立区域性局部复发(sLRR)的管理具有挑战性。本研究旨在确定与改善预后相关的特征。

方法

我们确定了最初接受调强放疗(IMRT)治疗的非鼻窦黏膜型 HNSCC 患者。我们描述了总生存期(OS)和局部区域控制(LRC)情况。使用 Cox 和 Fine-Gray 竞争风险分析进行生存和失败模式的多变量分析(MVA)。

结果

我们确定了 90 例可随访的患者。共有 67 例(74%)患者接受了根治性挽救治疗,23 例(26%)患者接受了姑息治疗。MVA 显示,初始 N 分类较低和使用挽救性全喉切除术(TL)或颈部清扫术(ND)与 OS 和 LRC 显著改善相关。

结论

相当一部分 sLRR 患者无法进行挽救治疗。在接受根治性治疗的患者中,TL 或 ND 明显与 OS 和 LRC 改善相关。

相似文献

1
Survival and disease progression following solitary locoregional recurrence after head and neck radiotherapy.头颈部放疗后单发区域性复发后的生存和疾病进展。
Head Neck. 2022 May;44(5):1153-1163. doi: 10.1002/hed.27012. Epub 2022 Feb 25.
2
Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.头颈部鳞状细胞癌放疗后复发的挽救性手术。
Otolaryngol Head Neck Surg. 2019 Jun;160(6):1023-1033. doi: 10.1177/0194599818818443. Epub 2018 Dec 11.
3
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
4
Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.初诊转移性头颈部鳞状细胞癌患者接受局部区域放疗的影响。
Oral Oncol. 2019 Jun;93:46-51. doi: 10.1016/j.oraloncology.2019.04.005. Epub 2019 Apr 15.
5
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.采用现代放射技术治疗后,局部晚期头颈部鳞状细胞癌患者的治疗失败模式和复发后结局。
JAMA Oncol. 2017 Nov 1;3(11):1487-1494. doi: 10.1001/jamaoncol.2017.0973.
6
The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.老年头颈部皮肤鳞状细胞癌的初级和辅助放疗的价值。
Radiat Oncol. 2021 Jun 12;16(1):105. doi: 10.1186/s13014-021-01832-3.
7
Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma.不同术后放疗策略治疗头颈部鳞状细胞癌的临床结果比较。
Jpn J Clin Oncol. 2017 Dec 1;47(12):1141-1150. doi: 10.1093/jjco/hyx137.
8
A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.头颈部癌再放疗后局部区域控制的预测列线图。
Radiother Oncol. 2014 Jun;111(3):382-7. doi: 10.1016/j.radonc.2014.06.003. Epub 2014 Jun 30.
9
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.在 COVID-19 大流行期间,头颈部癌症采用每分次 2.4 Gy 的低分割放射治疗:玛嘉烈公主医院的经验和建议。
Cancer. 2020 Aug 1;126(15):3426-3437. doi: 10.1002/cncr.32968. Epub 2020 Jun 1.
10
Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy.生物放疗治疗后头颈部鳞状细胞癌的挽救性手术
Head Neck. 2017 Jan;39(1):116-121. doi: 10.1002/hed.24549. Epub 2016 Jul 26.